1081.70 28.45 (2.70%)

80.89% Gain from 52W Low

217.9K NSE+BSE Volume

NSE 08 Apr, 2025 3:31 PM (IST)

Analyst Buy
Goldman Sachs initiates a 'Buy' rating on Suven Pharma; sets a target price of Rs 1,350 See details


Suven Pharmaceuticals Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Suven Pharmaceuticals Ltd. from all sources in a single place.

Load latest
22 Votes:
Buy 63.64%
Sell 13.64%
Hold 22.73%
BUY
SELL
HOLD